City

Sao Paulo (3)

Condition

SARS-CoV 2 (3)

Corona Virus Infection (2)

COVID-19 (1)

Coronavirus Infections (1)

Critical Illness (1)

Pulmonary Disease (1)

Respiratory Distress Syndrome, Adult (1)

SARS (Severe Acute Respiratory Syndrome) (1)

Sedentary Behavior (1)

Overall Status

Completed (2)

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

University of Sao Paulo General Hospital (2)

Apsen Farmaceutica S.A. (1)

Collaborator

Federal University of Sao Paulo (1)

Intervention

electronic questionnaire (1)

hydroxychloroquine sulfate (1)

hydroxychloroquine sulfate + azythromycin (1)

risk factors (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

SARS-CoV 2

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Coronavirus Infections, SARS-CoV 2, SARS (Severe Acute Respiratory Syndrome) Trial in São Paulo (Hydroxychloroquine Sulfate,

Withdrawn

Coronavirus Infections
+3 more

Hydroxychloroquine Sulfate
Hydroxychloroquine Sulfate + Azythromycin

São Paulo, Brazil

Apsen Farmacêutica S.A.

Nov 18, 2020

EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes

Completed

COVID-19
+3 more

Electronic questionnaire

São Paulo, Sao Paulo, Brazil

Marcelo Rodrigues dos Santos

Oct 21, 2020

Patients With COVID-19 Admitted to the ICU

Completed

SARS-CoV 2
+3 more

risk factors

Sao Paulo, SP, Brazil

Hospital das Clínicas -HCFMUSP

Aug 25, 2020